Effect of antioxidants alone and in combination with monounsaturated fatty acid-enriched diets on lipoprotein oxidation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 12, 1996, Pages 1465-1472

  Reaven, Peter ^a   Grasse, Barbara ^a   Barnett, Joellen ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

dense LDL; lipid peroxidation; monocyte; monounsaturated fatty acids; probucol

Indexed keywords

ALPHA TOCOPHEROL; PROBUCOL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

EID: 0030454220     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.12.1465     Document Type: Article

References (65)

1. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
2. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms - oxidation, inflammation and genetics. Circulation. 1995;91:2488-2496.
3. Navab M, Imes SS, Yama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991;88:2039-2046.
4. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990;87:5134-5138.
5. Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, DiCorleto PE. 7 Beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A. 1994;91:11452-11456.
6. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoprotein lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA. 1987;84:2995-2998.
7. McMurray HF, Parthasarathy S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest. 1993;92:1004-1008.
8. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modifications: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA. 1990;87:3894-3898.
9. Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, Khoo JC, Steinberg D, Witztum JL. Feasibility of using an oleate-enriched diet to reduce the susceptibility of low density lipoprotein to oxidative modification in humans. Am J Clin Nutr. 1991;54:701-706.
10. Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Donella M, Maiorins M, Ursini F. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low-density lipoprotein to oxidative modification. Arterioscler Thromb. 1992;12:529-533.
11. Abbey M, Belling GB, Noakes M, Hirata F, Nestel PJ. Oxidation of low density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr. 1993;57:391-398.
12. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 1991;32:1325-1332.
13. Jialal I, Norkus EP, Cristol L, Grundy SM. β-Carotene inhibits the oxidative modification of low-density lipoprotein susceptibility to oxidation. Arterioscler Thromb. 1993;13:601-608.
14. Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res. 1989; 30:1827-1834.
15. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci U S A. 1991;88:1646-1650.
16. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987;84:7725-7729.
17. Sparrow CP, Doebber TW, Olszewski J, Wum S, Ventre J, Stevens KA, Chao YS. Low density lipoprotein is protected from oxidation and' the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J Clin Invest. 1992;89:1885-1891.
18. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in Macaca Nemestrina by probucol, I: intimal lesion area correlates inversely with resistance of lipoproteins to oxidation. J Clin Invest. 1994;94:155-164.
19. Reaven P, Witztum JL. The role of oxidation of LDL in atherogenesis. Endocrinologist. 1995;5:44-54.
20. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
21. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ. Low-density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12: 187-195.
22. Stender S, Zilversmit DB. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Arteriosclerosis. 1981;1:38-49.
23. Nordestgaard BG, Zilversmit DB. Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits: differences in intimal clearance explained by size differences. Arteriosclerosis. 1989;9:176-183.
24. Krauss RM. Low density lipoprotein subclasses and risk of coronary artery disease. Curr Opin Lipidol. 1991;2:248-252.
25. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low-density lipoprotein subfraction in healthy subjects. Arterioscler Thromb. 1991;11:298-306.
26. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93:189-199.
27. Dejager S, Bruckert E, Chapman MJ. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res. 1993;34:295-308.
28. Sigari F, Sagrado T, Navab M, Hama S, Reaven PD. Particle size and platelet activating factor-acetylhydrolase influence LDL oxidation by an artery wall coculture system. J Invest Med. 1996;44:180A. Abstract.
29. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoproteins. Proc Natl Acad Sci U S A. 1981;78:6499-6503.
30. Cathcart MK, Morel DW, Chisolm GM. Monocytes and neutrophils oxidize low density lipoprotein, making it cytotoxic. J Leukoc Biol. 1985;38:341-350.
31. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA. 1985;82:3000-3004.
32. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled insulin-dependent diabetes mellitus. Diabetes. 1994;43:1010-1014.
33. Rabini RA, Fumelli P, Galassi R, Douseet N, Taus M, Ferretti G, Mazzanti L, Curatola G, Solera ML, Valdiguie P. Increased susceptibility to lipid oxidation of low density lipoprotein and erythrocyte membranes from diabetic patients. Metabolism. 1994;43:1470-1474.
34. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM. LDL subclass phenotypes and triglyceride metabolism in non-insulm-dependent diabetes. Arterioscler Thromb. 1992;12:1496-1502.
35. Selby JV, Austin MA, Newman B. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993;88: 381-387.
36. Cerami A, Vlassara H, Brownlee M. Role of advanced glycosylation products in complications of diabetes. Diabetes Care. 1988;11(suppl 1):73-79.
37. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A. 1993;90:6434-6438.
38. Kitahara M, Eyre HJ, Lynch RE, Rallison ML, Hill HR. Metabolic activity of diabetic monocytes. Diabetes. 1980;29:251-256.
39. Pronai L, Hiramatsu K, Saigusa Y, Nakazawa H. Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis. 1991;90:39-47.
40. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 1988;7:832-837.
41. Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-rich and oleate-rich diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb. 1993;14:557-566.
42. Reaven PD, Parthasarathy S, Beltz W, Witztum JL. The effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low-density lipoprotein against in vitro oxidation in man. Arterioscler Thromb. 1992;12:318-324.
43. Reaven PD, Herold DA, Barnett J, Edelman S. Effect of vitamin E on susceptibility of LDL and LDL subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care. 1995;18:807-816.
44. Boothby WM, Sandiford RB. Nomographic charts for the calculation of the metabolic rate by the gasometer method. Boston Med Surg J. 1921;185:337.
45. Esterbauer H, Striegl G, Puhl H, Rothender M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:67-75.
46. Thomas CE, Jackson RL. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins. J Pharmacol Exp Ther. 1991;256:1182-1188.
47. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
48. Boyum A. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation. Scand J Clin Lab Invest. 1968;21(suppl):77-89.
49. Cathcart MK, McNally AK, Morel DW, Chisolm GM. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein and conversion of low density lipoprotein to a cytotoxin. J Immunol. 1989;142:1963-1969.
50. Le T, Li X, Brown MV, Le N. An efficient single-spin density-gradient method for the isolation of Lp(a). Circulation. 1994;90(suppl I):I-503. Abstract.
51. Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr. 1988;48:612-619.
52. Kappus H, Diplock AT. Tolerance and safety of vitamin E: a toxicologic position report. Free Radic Biol Med. 1992;13:55-74.
53. Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-enriched and linoleate-enriched diets on the susceptibility of low density lipoprotein to oxidative modification in hypercholesterolemic subjects. J Clin Invest. 1993;91: 668-676.
54. Maher VM, Brown BG. Lipoprotein (a) and coronary heart disease. Curr Opin Lipidol. 1995;6:229-235.
55. Nachman R. The 1994 Runme Shaw Memorial Lecture: thrombosis and atherogenesis: molecular connections. Ann Acad Med Singapore. 1995;24:281-289.
56. Chapmann MJ, Huby T, Nigon F, Thillet J. Lipoprotein (a): implication in atherothrombosis. Atherosclerosis. 1994;110(suppl): 569-575.
57. Galle J, Bengen J, Schollmeyer P, Wanner C. Oxidized lipoprotein (a) inhibits endothelium-dependent dilation: prevention by high density lipoprotein. Eur J Pharmacol. 1994;265:111-115.
58. Galle J, Bengen J, Schollmeyer P, Wanner C. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a): role of oxygen-derived radicals. Circulation. 1995; 92:1582-1589.
59. Naruszewicz M, Selinger E, Davignon J. Oxidative modification of lipoprotein (a) and the effect of β-carotene. Metabolism. 1992; 41:1215-1224.
60. Sattler W, Kostner GM, Waeg G, Esterbauer H. Oxidation of lipoprotein Lp(a) A with low-density lipoproteins. Biochim Biophys Acta. 1991;1081:65-74.
61. Naruszewicz M, Selinger E, Davignon J. Oxidative modification of lipoprotein(a) and the effect of β-carotene. Metabolism. 1992;41: 1215-1224.
62. Tribble DL, Krauss RM, Lansberg MG, Thiel PM, van den Berg JJ. Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions. J Lipid Res. 1995;36:662-671.
63. Tribble DL. Lipoprotein oxidation in dyslipidemia: insights into general mechanisms affecting lipoprotein oxidative behavior. Curr Opin Lipidol. 1995;6:196-208.
64. Tribble DL, Thiel PM, Cook NE, van den Berg JM, Krauss RM. Enhanced oxidative lability of vitamin E in small, dense LDL versus large, buoyant LDL particles. Circulation. 1994;90(pt 2):I-409. Abstract.
65. Hama SY, Navab M, Cushing SD, Laks H, Fogelman AM. Factors modulating the modification of low-density lipoprotein in cocultures of human aortic wall cells. Circulation. 1993;88(suppl I):I-33. Abstract.